Article Information
vol. 12 no. 526
- Received for publication May 8, 2017
- Resubmitted June 24, 2019
- Accepted for publication December 3, 2019
- .
Author Information
- Shareen Forbes1,2,*,
- Andrew R. Bond1,†,
- Kayleigh L. Thirlwell3,4,
- Paul Burgoyne1,3,4,
- Kay Samuel3,
- June Noble1,
- Gary Borthwick1,
- David Colligan3,
- Neil W. A. McGowan3,
- Philip Starkey Lewis5,
- Alasdair R. Fraser3,
- Joanne C. Mountford3,
- Roderick N. Carter1,
- Nicholas M. Morton1,
- Marc L. Turner3,
- Gerard J. Graham4 and
- John D. M. Campbell3,4,*
- 1Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK.
- 2Clinical Islet Transplantation Programme, Royal Infirmary of Edinburgh, Edinburgh EH16 4SU, UK.
- 3Advanced Therapeutics, Scottish National Blood Transfusion Service, Edinburgh EH14 4BE, UK.
- 4Chemokine Research Group, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK.
- 5Medical Research Council (MRC) Centre for Regenerative Medicine, University of Edinburgh, 5 Little France Drive, Edinburgh EH16 4UU, UK.
- ↵*Corresponding author. Email: johncampbell3{at}nhs.net (J.D.M.C.); shareen.forbes{at}ed.ac.uk (S.F.)